Lisette Okkels Jensen

Showing 1-20 of 21 articles

Polymer-free biolimus-coated stents versus ultrathin-strut biodegradable polymer sirolimus-eluting stents: two-year outcomes of the randomised SORT OUT IX trial

Ellert-Gregersen J, Jensen LO, Jakobsen L, Freeman PM, Eftekhari A, Maeng M, Raungaard B, Engstroem T, Kahlert J, Hansen HS, Christiansen EH

January 5, 2022 | 10.4244/EIJ-D-21-00874

Coronary interventions

Thin- versus thick-strut polymer-free biolimus-eluting stents: the BioFreedom QCA randomised trial

Sabaté M, Jensen LO, Tilsted H, Moreno R, García del Blanco B, Macaya C, Pérez de Prado A, Cequier A, Pérez-Fuentes P, Schütte D, Costa R, Stoll H, Flensted Lassen J

June 25, 2021 | 10.4244/EIJ-D-20-01162

Coronary interventions

Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study

Pareek M, Madsen M, Warnakula Olesen K, Jensen LO, Christiansen EH, Dalby Kristensen S, Flensted Lassen J, Thuesen L, Bøtker H, Maeng M

December 6, 2019 | 10.4244/EIJ-D-19-00503

Interventions for heart failure

Impella CP or VA-ECMO in profound cardiogenic shock: left ventricular unloading and organ perfusion in a large animal model

Moller-Helgestad OK, Hyldebrandt JA, Banke A, Rud CS, Udesen NLJ, Linde L, Jensen LO, Schmidt H, Ravn HB, Moller JE

February 7, 2019 | 10.4244/EIJ-D-18-00684

Coronary interventions

Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)

Katagiri Y, Onuma Y, Asano T, Iñiguez A, Jensen LO, Cequier A, Hofma S, Christiansen EH, Suttorp M, Brugaletta S, Räber L, Sabaté M, Windecker S, Serruys P, Räber L, Sabaté M, Serruys P

December 7, 2018 | 10.4244/EIJ-D-18-00839

STEMI

One-year rehospitalisation after percutaneous coronary intervention: a retrospective analysis

Hansen KN, Bendix K, Antonsen L, Veien K, Maeng M, Junker A, Christiansen EH, Kahlert J, Terkelsen C, Christensen LB, Fallesen C, Bøtker H, Jensen LO

October 19, 2018 | 10.4244/EIJ-D-17-00800

Interventions for heart failure

Percutaneous biventricular cardiac assist device in cardiogenic shock and refractory cardiac arrest

Ellert J, Jensen MJ, Jensen LO, Moller JE

April 6, 2018 | 10.4244/EIJ-D-17-00637

How should I treat a bioresorbable vascular scaffold edge restenosis and intra-scaffold dissection?

Fallesen C, Antonsen L, Thayssen P, Jensen LO

February 20, 2018 | 10.4244/EIJ-D-17-00309

Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial)

Jensen LO, Maeng M, Raungaard B, Hansen K, Kahlert J, Jensen S, Hansen H, Flensted Lassen J, Bøtker H, Christiansen EH

January 19, 2018 | 10.4244/EIJ-D-17-00731

Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents

Jakobsen L, Christiansen EH, Maeng M, Hansen K, Kristensen SD, Bøtker H, Terkelsen C, Jensen S, Raungaard B, Madsen M, Flensted Lassen J, Jensen LO

December 20, 2017 | 10.4244/EIJ-D-17-00434

Coronary interventions

Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study

Räber L, Onuma Y, Brugaletta S, Garcia-Garcia H, Backx B, Iñiguez A, Jensen LO, Cequier-Fillat A, Pilgrim T, Christiansen EH, Hofma S, Suttorp M, Serruys P, Sabaté M, Windecker S

July 20, 2016 | 10.4244/EIJY15M08_03

Coronary interventions

Outcome with invasive versus medical treatment of stable coronary artery disease: influence of perfusion defect size, ischaemia, and ejection fraction

Simonsen J, Johansen A, Gerke O, Mickley H, Thomassen A, Hess S, Rask C, Tamadoni M, Jensen LO, Hallas J, Vach W, Hoilund-Carlsen P

February 19, 2016 | 10.4244/EIJV11I10A226

Very late stent thrombosis caused by neoatherosclerotic plaque rupture

Hougaard M, Thayssen P, Hansen H, Jensen LO

April 20, 2015 | 10.4244/EIJV10I12A251

Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial

Antonsen L, Thayssen P, Hansen H, Maeng M, Tilsted H, Bøtker H, Ravkilde J, Madsen M, Sørensen H, Thuesen L, Flensted Lassen J, Jensen LO

June 20, 2014 | 10.4244/EIJV10I2A35

Influence of high-dose lipid lowering treatment compared to low-dose lipid lowering treatment on plaque composition assessed by intravascular ultrasound virtual histology in patients with ST-segment elevation acute myocardial infarction: the VIRHISTAMI trial

Egede R, Jensen LO, Hansen H, Hansen K, Junker A, Thayssen P

February 22, 2013 | 10.4244/EIJV8I10A182

Sex- and age-related differences in clinical outcome after primary percutaneous coronary intervention

Jakobsen L, Niemann T, Thorsgaard N, Nielsen T, Thuesen L, Flensted Lassen J, Jensen LO, Thayssen P, Ravkilde J, Tilsted H, Mehnert F, Johnsen SP

December 28, 2012 | 10.4244/EIJV8I8A139

The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation

Thayssen P, Jensen LO, Flensted Lassen J, Tilsted H, Kaltoft A, Christiansen EH, Hansen K, Ravkilde J, Maeng M, Krusell L, Madsen M, Sørensen H, Thuesen L

September 28, 2012 | 10.4244/EIJV8I5A91

Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease

Jensen LO, Thayssen P, Farkas D, Hougaard M, Terkelsen C, Tilsted H, Maeng M, Junker A, Flensted Lassen J, Horv E, Sørensen H, Thuesen L

August 24, 2012 | 10.4244/EIJV8I4A72

Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial

Jensen LO, Maeng M, Thayssen P, Villadsen A, Krusell L, Bøtker H, Pedersen K, Aaroe J, Christiansen EH, Vesterlund T, Hansen K, Ravkilde J, Tilsted H, Flensted Lassen J, Thuesen L

July 29, 2011 | 10.4244/EIJV7I3A56

Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes

Jensen LO, Tilsted H, Thayssen P, Kaltoft A, Maeng M, Flensted Lassen J, Noerregaard Hansen K, Madsen M, Ravkilde J, Johnsen S, Sørensen H, Thuesen L

April 12, 2010

1
2

Latest news

Three-year TAVI outcomes for BAV vs TAV

FREE ARTICLE - Dao Zhou et al.

January 20, 2022

Percutaneous management of left ventricular assist device outflow graft obstruction

FREE ARTICLE - Aleksandra Gasecka et al.

January 19, 2022

EuroCTO Club Consensus on Dual Lumen Microcatheters for CTO Recanalisation; Predicting Radial Crossover in ACS, the MATRIX score; DAPT duration for BRS; and more…

December 17, 2021

Lipid-rich plaque density and LDL-C in statin-treated vs statin-naïve patients

FREE ARTICLE - Rebecca Torguson et al.

January 17, 2022

Redo transcatheter mitral valve replacement in mitral annular calcification

FREE ARTICLE - Jennifer Jdaidani et al

January 13, 2022

TAVI vs SAVR in bicuspid aortic valve stenosis

FREE ARTICLE - Monil Majmundar et al.

January 12, 2022

Management of MR patients undergoing TMVI screening

FREE ARTICLE - Sebastian Ludwig et al.

January 7, 2022

Valvular disease